SER-287
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SER-287, covering 2019-06-20 to 2022-06-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis [Phase 2]